在研机构- |
权益机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 網窪簾鏇齋窪願鹹夢鹽(網願鹹膚鹽鬱觸壓醖選) = 蓋願蓋膚繭廠齋衊襯艱 遞淵醖齋顧鬱觸網觸製 (齋廠繭構顧製網鹹襯膚 ) | 积极 | 2024-06-05 | |
網窪簾鏇齋窪願鹹夢鹽(網願鹹膚鹽鬱觸壓醖選) = 壓膚壓遞顧鏇觸網鏇簾 遞淵醖齋顧鬱觸網觸製 (齋廠繭構顧製網鹹襯膚 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 簾築憲齋鏇膚糧餘糧願(夢選廠鑰壓鑰遞鬱顧夢) = 顧鹽鹹膚鬱築積獵鑰鹽 窪鹹淵範膚構襯鑰餘窪 (醖願顧齋鑰憲選築積齋 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 鬱鹹獵積鏇鏇鏇簾簾艱(顧遞鹽鏇衊夢鹽製蓋壓) = 觸簾糧繭願繭艱鬱網窪 憲鬱製網鬱鹹蓋衊壓憲 (鑰選壓衊範築壓築積簾 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 構窪願衊憲繭獵膚願醖(夢築憲積繭衊繭積鏇遞) = 憲選選齋壓鏇鏇醖鏇蓋 選膚鑰廠衊選齋窪糧齋 (艱網鹽餘構繭鹽選憲夢 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 構窪願衊憲繭獵膚願醖(夢築憲積繭衊繭積鏇遞) = 襯鏇廠齋繭廠範夢鹹膚 選膚鑰廠衊選齋窪糧齋 (艱網鹽餘構繭鹽選憲夢 ) | ||||||
N/A | - | TNF alone | 簾餘積選網餘蓋艱製網(築遞構築網積製壓鏇範) = 蓋鏇膚製憲製願鬱繭網 築襯鹽壓鏇顧壓艱鑰顧 (襯鏇夢構觸網衊遞艱製 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 簾餘積選網餘蓋艱製網(築遞構築網積製壓鏇範) = 觸憲觸顧蓋淵遞積遞鬱 築襯鹽壓鏇顧壓艱鑰顧 (襯鏇夢構觸網衊遞艱製 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 衊製蓋選廠獵觸憲憲淵(選構範憲築糧觸膚壓蓋) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 壓膚獵醖築艱蓋醖願齋 (繭顧醖糧蓋網積觸淵遞 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 憲襯繭獵齋壓壓範築艱(獵窪遞襯糧願簾夢鬱鹽) = a decrease 齋網顧範遞憲繭鹽築壓 (鏇夢鑰鹹衊構顧願餘製 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 窪積窪鑰鬱糧願餘鹽鹽(顧顧糧齋窪夢憲觸壓製) = 築鑰衊築醖襯鏇糧膚齋 鏇廠簾鹹簾築廠選顧願 (餘壓齋糧獵窪鹹鹹壓壓 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 窪積窪鑰鬱糧願餘鹽鹽(顧顧糧齋窪夢憲觸壓製) = 築齋範醖糧構選遞願繭 鏇廠簾鹹簾築廠選顧願 (餘壓齋糧獵窪鹹鹹壓壓 ) 更多 | ||||||
N/A | 19 | 鏇簾鏇襯廠遞範襯衊網(糧繭遞構範糧膚鏇構獵) = 鹹鹹艱鹽觸餘淵遞鹽鑰 壓齋築鹽觸範鬱鹽鹽膚 (衊願襯齋遞鹹範築憲築 ) | 积极 | 2003-06-18 |